openPR Logo
Press release

Investigation announced for Investors in shares of Masimo Corporation (NASDAQ: MASI) over possible Violations of Securities Laws

An investigation for investors in Masimo Corporation (NASDAQ: MASI) shares over potential securities laws violations.

An investigation for investors in Masimo Corporation (NASDAQ: MASI) shares over potential securities laws violations.

An investigation was announced for investors of Masimo Corporation (NASDAQ: MASI) shares over potential securities laws violations by Masimo Corporation in connection with certain financial statements.

Investors who purchased shares of Masimo Corporation (NASDAQ: MASI), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether a series of statements by Masimo Corporation regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Irvine, CA based Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. Masimo Corporation reported that its annual Total Revenue rose from over $2.03 billion in 2022 to over $2.04 billion in 2023, and that its Net Income declined from $143.5 million in 2022 to $81.5 million in 2023.

On May 7, 2024, Masimo Corporation filed its quarterly report on Form 10-Q with Securities and Exchange Commission ("SEC") which, among other things, announced that the "Company received a civil investigative demand from the DOJ [Department of Justice] pursuant to the False Claims Act, 31 U.S.C. §§ 3729-3733, dated March 25, 2024, seeking documents and information related to customer returns of the Company's Rad-G® and Rad-97® products, including returns related to the Company's recall of select Rad-G® products in 2024."

Shares of Masimo Corporation (NASDAQ: MASI) declined from $153.93 per share on March 25, 2024, to as low as $114.32 per share on May 08, 2024.

Those who purchased shares of Masimo Corporation (NASDAQ: MASI) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Investors in shares of Masimo Corporation (NASDAQ: MASI) over possible Violations of Securities Laws here

News-ID: 3557572 • Views:

More Releases from Shareholders Foundation, Inc.

Novo Nordisk A/S (NYSE: NVO) Long Term Investor Alert: Investigation of potential Wrongdoing
Novo Nordisk A/S (NYSE: NVO) Long Term Investor Alert: Investigation of potentia …
An investigation on behalf of current long-term investors in shares of Novo Nordisk A/S (NYSE: NVO) concerning potential breaches of fiduciary duties by certain directors and officers was announced. Investors who are current long term investors in Novo Nordisk A/S (NYSE: NVO) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for long term investors in
Lawsuit filed for Investors who lost money with shares of Fortinet, Inc. (NASDAQ: FTNT)
Lawsuit filed for Investors who lost money with shares of Fortinet, Inc. (NASDAQ …
An investor, who purchased shares of Fortinet, Inc. (NASDAQ: FTNT), filed a lawsuit over alleged violations of Federal Securities Laws by Fortinet, Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Fortinet, Inc. (NASDAQ: FTNT) have certain options and for certain investors are short and strict deadlines running. Deadline: November 21, 2025. NASDAQ: FTNT investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)
CTO Realty Growth, Inc. (NYSE: CTO) Investor Alert: Deadline in Lawsuit on October 07, 2025
CTO Realty Growth, Inc. (NYSE: CTO) Investor Alert: Deadline in Lawsuit on Octob …
A deadline is coming up on October 07, 2025in the lawsuit filed for certain investors of CTO Realty Growth, Inc. (NYSE: CTO) over alleged securities laws violations by CTO Realty Growth, Inc. Investors who purchased shares of CTO Realty Growth, Inc. (NYSE: CTO) have certain options and there are strict and short deadlines running. Deadline: October 07, 2025. CTO Realty Growth, Inc. (NYSE: CTO) stockholders should contact the Shareholders Foundation at
Alert: Lawsuit filed for Investors who lost money with shares of Jasper Therapeutics, Inc. (NASDAQ: JSPR)
Alert: Lawsuit filed for Investors who lost money with shares of Jasper Therapeu …
An investor, who purchased shares of Jasper Therapeutics, Inc. (NASDAQ: JSPR), filed a lawsuit over alleged violations of Federal Securities Laws by Jasper Therapeutics, Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Jasper Therapeutics, Inc. (NASDAQ: JSPR) have certain options and for certain investors are short and strict deadlines running. Deadline: November 18, 2025. NASDAQ: JSPR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com

All 5 Releases


More Releases for Masimo

Health Surveillance Market Next Big Thing | Major Giants Garmin, Masimo, Withing …
HTF MI recently introduced Global Health Surveillance Market study with 143+ pages in-depth overview, describing about the Product / Industry Scope and elaborates market size (2025-2032). The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence. Major Companies in Health Surveillance Market are: Philips (Netherlands), Abbott Laboratories (US), Siemens Healthineers (Germany), Medtronic (US), GE Healthcare (US), Biotronik (Germany), Honeywell
Wearable Patch Market Is Booming So Rapidly | Feeligreen, Masimo, Hocoma
The latest study released on the Global Wearable Patch Market by USD Analytics Research evaluates market size, trend, and forecast to 2030. The Wearable Patch market study covers significant research data and proofs to be a handy resource document for managers, analysts, industry experts and other key people to have ready-to-access and self-analyzed study to help understand market trends, growth drivers, opportunities and upcoming challenges and about the competitors. Key Players
Biosensors Market Is Booming Worldwide with Masimo, NeuroSky, Xsensio
Global Biosensors Market is the most recent research report from USD Analytics that analyses market risk side data, highlights opportunities, and uses that data to support tactical as well as strategic the decision-making. A thorough investigation was conducted to provide the most recent information on the market's key characteristics for Biosensors. Regarding revenue size, production, CAGR, consumption, gross margin, pricing, and other important elements, the study makes a variety of
Standalone Capnography Equipment Market | Drager, Hill-Rom, Masimo, Medtronic
The global standalone capnography equipment market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the standalone capnography equipment market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants. From the perspective of market dynamics, this report explores the factors driving the growth
Wireless Health Market to Witness Stunning Growth | Baxter, Masimo, Digi
The Wireless Health Market study with 65+ market data Tables, Pie charts & Figures is now released by HTF MI. The research assessment of the Market is designed to analyze futuristic trends, growth factors, industry opinions, and industry-validated market facts to forecast till 2029. The market Study is segmented by key a region that is accelerating the marketization. This section also provides the scope of different segments and applications that
Global Capnography Equipments Market Outlook 2018 Medtronic, Philips Healthcare, …
Recently added detailed market study "Global Capnography Equipments Market" examines the performance of the Capnography Equipments market 2018. It encloses an in-depth Research of the Capnography Equipments market state and the competitive landscape globally. This report analyzes the potential of Capnography Equipments market in the present and the future prospects from various angles in detail. The Global Capnography Equipments Market 2018 report includes Capnography Equipments market Revenue, market Share, Capnography Equipments